• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Infectious Disease

H1N1 influenza vaccination not associated with congenital malformations

byQasim HussainiandDeepti Shroff Karhade
September 20, 2016
in Infectious Disease, Obstetrics, Pediatrics, Public Health
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. H1N1 vaccination is not linked with increased risk for overall congenital malformations.

2. Risk increases for specific malformations could not be ruled out.

Evidence Rating Level: 1 (Excellent)

Study Rundown: During the 2009 H1N1 influenza epidemic, approximately 200 million individuals worldwide were effected and several national vaccination campaigns initiated. Previous studies have investigated a relationship between the vaccination of pregnant women and subsequent congenital malformation in the offspring. While most demonstrated mixed evidence, several studies did not consider the potential role of confounding error that may occur due to genetic and shared environmental factors.

In this population-based prospective cohort study, registry data from seven Swedish health centers comprising approximately 60% of the country’s population were obtained. Approximately 40,983 of the offspring were prenatally exposed to the government-sponsored AS03-adjuvanted monovalent vaccine (Pandemrix), with 14,385 in the first trimester and 7,502 in the first 8 weeks when the risk of congenital malformations may be highest. Overall, no increased risk was found between the exposed and unexposed offspring. Further, no statistically significant risk differences were found in a separate sibling analysis. In a subgroup analysis, however, a significant relationship between the risk of oral cleft and vaccine exposure was present. The current study includes more Pandemrix-exposed offspring compared to previous studies, successfully eliminates recall bias related errors, and examines the potential effects of confounding.

Overall, the study suggests H1N1 vaccination is not associated with congenital malformations when intrafamilial factors are taken into consideration. Limitations include malformations occurring in prior pregnancies that may influence the decision to be vaccinated during the study period. The study was also based on live births and cannot dismiss miscarriage or stillbirths caused by congenital malformations. Future studies should consider H1N1 vaccination increasing the risk of specific malformations.

Click to read the study, published in the Annals of Internal Medicine

RELATED REPORTS

Maternal influenza vaccine during pregnancy not linked to adverse early childhood outcomes

Influenza vaccine administered to all pediatric emergency department patients may be cost-effective

Older adults receiving recombinant influenza vaccine better protected against influenza

Relevant Reading: Influenza vaccination during pregnancy: a systematic review of fetal death, spontaneous abortion, and congenital malformation safe outcomes

In-Depth [prospective cohort]: Registry data on influenza A(H1N1)pdm09 vaccinations administered between 2009 and 2010 were linked to pregnant women during the pandemic, pregnancy characteristics, and malformation data. Vaccination during the first trimester and in the first 8 weeks of pregnancy were examined. Controls comprised of pregnancies during the same period but without recorded influenza A(H1N1)pdm09 vaccination. Swedish Medical Birth Register was utilized to obtain most covariate and pregnancy data, and the Swedish Total Population Register was used to identify siblings of offspring that were prenatally exposed to the vaccine during pregnancy. Congenital malformation was the main outcome measure and these were examined in offspring born between 1 October 2009 to 1 October 2011, approximately the period between the start of the campaign and 9 months after the end of the campaign (n = 97,869; 40,983 exposed and 56,886 unexposed).

About 4.98% and 4.96% were the adjusted risks in the exposed and unexposed offspring. Only malformations during the first year of life were included. The sibling comparators were born between 2001 and 2011. All exposed offspring together with their siblings were used in the study (n = 5597; 2383 exposed and 3214 unexposed). Adjusted odds ratio for any malformation was 0.98 (CI 0.89 to 1.07) for a full pregnancy and 1.03 (CI 0.88 to 1.19) for the first trimester. A subanalysis measured the risk of congenital heart disease, oral cleft, and limb deficiency. In this analysis, risk differences during the first 8 weeks of pregnancy were 0.12% for CHD, 0.10% for oral cleft and 0.02% for limb deficiency.

Image: PD

©2016 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: Influenza vaccine
Previous Post

Hospitals are employing more physicians, but this does not necessarily improve care

Next Post

Azithromycin not effective in acute asthma exacerbations: The AZALEA trial

RelatedReports

AAP guidelines for pneumococcal vaccination in high-risk groups released
Chronic Disease

Maternal influenza vaccine during pregnancy not linked to adverse early childhood outcomes

June 17, 2021
Child maltreatment associated with poor adult socioeconomic status
Emergency

Influenza vaccine administered to all pediatric emergency department patients may be cost-effective

November 10, 2017
Live attenuated vaccine less effective in recent influenza season
Emergency

Older adults receiving recombinant influenza vaccine better protected against influenza

June 30, 2017
Significant percentage of pediatricians dismiss families who refuse vaccines
Infectious Disease

Influenza vaccination in children decreases risk of death

April 3, 2017
Next Post
Microbe-rich environment associated with lower rates of asthma

Azithromycin not effective in acute asthma exacerbations: The AZALEA trial

HOSPITAL score predicts risk of 30-day potentially avoidable readmission to hospital

Total inpatient antibiotic use consistent from 2006 to 2012

Digital imaging detects sight-threatening retinopathy of prematurity

CPAP is superior to nasal high-flow therapy as primary support for preterm infants

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

Get 2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Wellness Check: Mental Health
  • #VisualAbstract: Addition of elotuzumab to lenalidomide and dexamethasone did not significantly improve survival outcomes in newly diagnosed, transplant-ineligible multiple myeloma
  • #VisualAbstract: Pretreatment with radiotherapy and two cycles of concurrent cisplatin may reduce toxicity in locally advanced nasopharyngeal carcinoma
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.